This Analyst Is Defending Acorda Therapeutics; Shares Still Down 7% In A Week
February 17, 2015 at 17:55 PM EST
Acorda Therapeutics Inc (NASDAQ: ACOR) shares could see several catalysts in 2015 that may drive prices higher, an analyst said ...